methods: In this retrospective, single-centre, double-blind, clinical study, we assessed whether selective intracoronary administration of adenosine distal to the occlusion site immediately before initial balloon inflation reduces microvascular obstruction (MVO) as assessed with cardiac magnetic resonance imaging (MRI). Using contrast-enhanced sequences, microvascular obstruction (MVO) was calculated. We found 40 patients presenting with STEMI within 12 h from symptom onset who were eligible for the study. In 40/40 (100%) patients receiving study drug, MRI was performed on Day1 post primary angioplasty.
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results: The prevalence of MVO was reduced in the adenosine-treated patients (45%) compared to 85% of control patients (P=0.0043). We found that the size of MVO in adenosine-treated patients was significantly reduced (0.35g) compared to 0.91 g in the control group (P=0.027). There was no statistically significant difference in TIMI flow and clinical outcomes after primary PCI.
conclusion: We found significant evidence that selective high-dose intracoronary administration of adenosine distal to the occlusion site of the culprit lesion in STEMI patients results in a decrease in microvascular obstruction.
